Karni A - Search Results

1

Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients.

Levy YA, Mausner-Fainberg K, Vaknin-Dembinsky A, Amidror T, Regev K, Karni A. Levy YA, et al. Among authors: karni a. J Neuroimmunol. 2015 Jan 15;278:85-9. doi: 10.1016/j.jneuroim.2014.12.010. Epub 2014 Dec 10. J Neuroimmunol. 2015. PMID: 25595256

2

Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.

Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A. Karni A, et al. Arch Neurol. 1999 Mar;56(3):311-5. doi: 10.1001/archneur.56.3.311. Arch Neurol. 1999. PMID: 10190821

3

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.

Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL. Karni A, et al. J Neuroimmunol. 2004 Jan;146(1-2):189-98. doi: 10.1016/j.jneuroim.2003.10.036. J Neuroimmunol. 2004. PMID: 14698862

4

Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells.

Abraham M, Shapiro S, Karni A, Weiner HL, Miller A. Abraham M, et al. Among authors: karni a. J Neuroimmunol. 2005 Jun;163(1-2):157-64. doi: 10.1016/j.jneuroim.2005.02.001. Epub 2005 Apr 2. J Neuroimmunol. 2005. PMID: 15885317

5

Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.

Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. Azoulay D, et al. Among authors: karni a. J Neuroimmunol. 2005 Oct;167(1-2):215-8. doi: 10.1016/j.jneuroim.2005.07.001. J Neuroimmunol. 2005. PMID: 16083971 Clinical Trial.

6

Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.

Azoulay D, Urshansky N, Karni A. Azoulay D, et al. Among authors: karni a. J Neuroimmunol. 2008 Mar;195(1-2):186-93. doi: 10.1016/j.jneuroim.2008.01.010. Epub 2008 Mar 10. J Neuroimmunol. 2008. PMID: 18329726

7

Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.

Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A. Azoulay D, et al. Among authors: karni a. J Neuroimmunol. 2009 Jun 25;211(1-2):114-9. doi: 10.1016/j.jneuroim.2009.04.004. Epub 2009 May 5. J Neuroimmunol. 2009. PMID: 19419774

8

Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Farhum F, Karni A. Urshansky N, et al. Among authors: karni a. J Neurol Sci. 2010 Aug 15;295(1-2):31-7. doi: 10.1016/j.jns.2010.05.019. Epub 2010 Jun 11. J Neurol Sci. 2010. PMID: 20541775

9

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A. Urshansky N, et al. Among authors: karni a. J Neuroimmunol. 2011 Mar;232(1-2):171-8. doi: 10.1016/j.jneuroim.2010.10.007. Epub 2010 Nov 26. J Neuroimmunol. 2011. PMID: 21111488

10

Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.

Auriel E, Regev K, Dori A, Karni A. Auriel E, et al. Among authors: karni a. Muscle Nerve. 2011 Jun;43(6):893-4. doi: 10.1002/mus.22077. Muscle Nerve. 2011. PMID: 21607970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters